Effect of YM294, recombinant human inter
โ
Katsunari Taguchi; Masaharu Asano
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 478 KB
We investigated the effects of YM294, recombinant human interleukin-11, on changes in blood cell levels in carboplatin-treated rats. Continuous infusion of YM294 was carried out by either intravenous or subcutaneous injection (10 and 100 micrograms/rat/day) for 14 days via an implanted osmotic pump.